BioCardia, Inc.
BCDA
$2.23
-$0.02-0.89%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 18.83% | 31.33% | 38.36% | 34.21% | 14.45% |
| Total Depreciation and Amortization | -25.93% | -20.24% | -15.29% | -17.20% | -7.95% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -19.17% | -24.42% | -27.62% | -22.46% | -10.45% |
| Change in Net Operating Assets | -4,705.56% | -1,024.81% | -418.25% | -67.34% | -94.74% |
| Cash from Operations | 9.28% | 19.53% | 34.32% | 33.68% | 12.38% |
| Capital Expenditure | -200.00% | 50.00% | 64.29% | 89.29% | 96.08% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -200.00% | 50.00% | 64.29% | 89.29% | 96.08% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 65.74% | 140.47% | 71.27% | -31.82% | -3.01% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -105.94% | -89.12% | -133.92% | 1.67% | 4.35% |
| Cash from Financing | 61.18% | 149.60% | 65.09% | -34.34% | -2.85% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.00% | 120.26% | 164.05% | 33.07% | 22.96% |